A study published earlier this week in Nature Communications using claims data from the US Veterans Affairs (VA) Healthcare ...

The anticipated rollout of updated Covid vaccines this fall might be at risk after a change by Health and Human Services ...

Pfizer’s first-quarter revenue missed analyst estimates as it faces an “uncertain and volatile external environment.” ...

COVID-19 booster is here, and public health officials are urging seniors and immunocompromised people to get protected ahead ...

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

Pfizer said on Tuesday it would generate $1.7 billion more in savings from cost cuts to its manufacturing and research ...

Pfizer Inc. and BioNTech SE failed to knock out any of Alnylam Pharmaceuticals Inc.’s patents in a case over the partners’ ...

EPS estimates, maintains 2025 guidance, and targets $5.7 billion in cost savings through automation and R&D streamlining.

Confusion over the FDA delay in granting full approval to Novavax’s Covid-19 vaccine deepened over the weekend, with possible ...

The agency suggested that clinical trials in humans may be required for updated Covid shots, raising questions about whether ...

The US Department of Health and Human Services said it will require that all new vaccines be tested in placebo-controlled ...

Under President Trump, the Food and Drug Administration may no longer approve seasonal COVID-19 vaccines updated for the ...